Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Tildrakizumab Prefilled Syringe
DRUG
2 trials
Sponsors
Brigham and Women's Hospital
, University of California, San Francisco
Conditions
Pemphigoid, Bullous
Psoriasis Vulgaris
Early Phase 1
The Effects of Tildrakizumab in Treatment of Bullous Pemphigoid
NCT04465292
Brigham and Women's Hospital
Pemphigoid, Bullous
Start: 2020-09-01
End: 2023-05-01
Target: 16
Updated: 2020-07-10
Phase 4
Psoriatic Immune Response to Tildrakizumab
Recruiting
NCT05390515
University of California, San Francisco
Psoriasis Vulgaris
Start: 2022-09-01
End: 2028-09-01
Target: 10
Updated: 2026-06-04